ArticleKidney international reports2021

Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial.

Markus Ketteler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.